Elena Palassini

Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial

Alessandro Gronchi, Stefano Ferrari, Vittorio Quagliuolo et al. · The Lancet Oncology · 2017 · 473 citations

Tumor Biology, Surgical Oncology, Malignant Disease +10

Neoadjuvant Chemotherapy in High-Risk Soft Tissue Sarcomas: Final Results of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) Sarcoma Groups

Alessandro Gronchi, Emanuela Palmerini, Vittorio Quagliuolo et al. · Journal of Clinical Oncology · 2020 · 245 citations · Full text

Sunitinib in advanced alveolar soft part sarcoma: evidence of a direct antitumor effect

Silvia Stacchiotti, Tiziana Negri, Nadia Zaffaroni et al. · Annals of Oncology · 2011 · 219 citations · Full text

Medicine, Pathology, Direct Antitumor Effect +4

Chordoma of the Mobile Spine and Sacrum: A Retrospective Analysis of a Series of Patients Surgically Treated at Two Referral Centers

Silvia Stacchiotti, Paolo G. Casali, Salvatore Lo Vullo et al. · Annals of Surgical Oncology · 2009 · 191 citations

Referral Centers, Spinal Cord Injury, Retrospective Analysis +9

Preoperative imatinib mesylate for unresectable or locally advanced primary gastrointestinal stromal tumors (GIST)

Marco Fiore, Elena Palassini, Elena Fumagalli et al. · European Journal of Surgical Oncology · 2008 · 178 citations

Surgical Oncology, Gastrointestinal Oncology, Preoperative Imatinib Mesylate +8